Chemoinformaics analysis of CAFFEIC-ACID-ETHYL-ESTER
| Molecular Weight | 236.267 | nRot | 5 |
| Heavy Atom Molecular Weight | 220.139 | nRig | 8 |
| Exact Molecular Weight | 236.105 | nRing | 1 |
| Solubility: LogS | -2.631 | nHRing | 0 |
| Solubility: LogP | 3.128 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 33 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 17 | No. of Aromatic Carbocycles | 1 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 6 |
| nHA | 4 | APOL | 35.5867 |
| nHD | 2 | BPOL | 18.6553 |
| QED | 0.356 |
| Synth | 2.07 |
| Natural Product Likeliness | 0.848 |
| NR-PPAR-gamma | 0.904 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.034 |
| HIA | 0.013 |
| CACO-2 | -4.702 |
| MDCK | 0.0000255 |
| BBB | 0.15 |
| PPB | 0.953821 |
| VDSS | 0.368 |
| FU | 0.0568305 |
| CYP1A2-inh | 0.972 |
| CYP1A2-sub | 0.285 |
| CYP2c19-inh | 0.745 |
| CYP2c19-sub | 0.086 |
| CYP2c9-inh | 0.765 |
| CYP2c9-sub | 0.893 |
| CYP2d6-inh | 0.683 |
| CYP2d6-sub | 0.718 |
| CYP3a4-inh | 0.457 |
| CYP3a4-sub | 0.221 |
| CL | 15.627 |
| T12 | 0.917 |
| hERG | 0.068 |
| Ames | 0.289 |
| ROA | 0.468 |
| SkinSen | 0.952 |
| Carcinogencity | 0.414 |
| EI | 0.919 |
| Respiratory | 0.194 |
| NR-Aromatase | 0.552 |
| Antiviral | Yes |
| Prediction | 0.574564 |